Search results
Argenx Surges After Its Bread-And-Butter Drug Wins Another FDA Approval
Investor's Business Daily· 1 hour agoThat's up from her prior estimate of $3.2 billion. "We are not surprised by the approval and label...
A Tiny, “Empty” Balcony Transforms into a Colorful Summer Retreat
Apartment Therapy via Yahoo News· 2 hours agoThis content is presented by The Home Depot; it was created independently by our editorial team....
Intra-Cellular Therapies (NASDAQ:ITCI) PT Raised to $94.00 at Needham & Company LLC
ETF DAILY NEWS· 5 days agoThe brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. Several other research firms have also issued reports on ITCI. Bank of America increased their target price ...
How Cupping Therapy Can Benefit Your Health
Mercola· 7 days agoThen, the air is vacuumed out from the cups, sucking your skin and fascia upward into the cup. The origins aren’t clear, but historians believe that cupping therapy originated ...
From pizza to physical therapy: Castaldi family maintains footprint in Minooka
The Times-Tribune, Scranton, Pa. via Yahoo News· 1 day agoThe former site of a longtime grocery store and butcher shop in Minooka now houses a physical therapy business and the same family is still running the show. Castaldi's Market ...
Delaying Statin Therapy in Diabetes Increases CV Risk
Medscape· 2 days agoPatients with type 1 and 2 diabetes who delay treatment with recommended statin therapy to address...
7 Biotech Stocks to Buy on the Dip: June 2024
InvestorPlace· 5 hours agoFundamentally, the biotechnology sphere enjoys a powerful catalyst: wealth without health means nothing. With that in mind, the below biotech stocks to...
This California company is selling products with human fecal matter to Canadians
San Jose Mercury News· 3 hours agoThe United States Food and Drug Administration (FDA) has issued a warning letter to a company...
Obesity drugs from Altimmune, Hengrui show potential; Lilly details Zepbound sleep apnea data
BioPharma Dive via Yahoo Finance· 9 hours agoResearchers also reported the elimination of severe hypoglycemic events in these three individuals,...
Taysha Gene Therapies (NASDAQ:TSHA) Given Overweight Rating at Cantor Fitzgerald
ETF DAILY NEWS· 5 days agoJMP Securities restated a “market outperform” rating and issued a $5.00 price target on shares of Taysha Gene Therapies in a research note on Wednesday, March 20th. Jefferies ...
